Lipid-lowering therapy after an atherosclerotic event
- 15 September 1989
- journal article
- editorial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 64 (10) , 693-695
- https://doi.org/10.1016/0002-9149(89)90511-0
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: The finnish multicenter studyThe American Journal of Cardiology, 1988
- Changes in high-density lipoprotein subfraction distribution and increased cholesteryl ester transfer after probucolThe American Journal of Cardiology, 1988
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsArchives of internal medicine (1960), 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Lovastatin (Mevinolin) in the Treatment of Heterozygous Familial HypercholesterolemiaAnnals of Internal Medicine, 1987
- Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery diseaseThe American Journal of Cardiology, 1986
- Effects of probucol on xanthomata regression in familial hypercholesterolemiaThe American Journal of Cardiology, 1986
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- Clofibrate and Niacin in Coronary Heart DiseaseJAMA, 1975